Mascha Binder

Ernst Grube Str. 40
Halle, NI 06120, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 185 publications

α2,3-sialylation on human naïve T cells restrains bispecific engager-mediated anti-tumor immunity.

α2,3-sialylation on human naïve T cells restrains bispecific engager-mediated anti-tumor immunity.

Journal: bioRxiv : the preprint server for biology

Published: August 20, 2026

Cytotoxic CD39+ tumor-associated NK cells respond to NKG2A blockade in lung cancer.

Cytotoxic CD39+ tumor-associated NK cells respond to NKG2A blockade in lung cancer.

Journal: Science immunology

Published: June 05, 2026

CD96 marks a phenotypically distinct checkpoint-associated HCV-specific CD8+ T-cell subset featuring memory-associated states.

CD96 marks a phenotypically distinct checkpoint-associated HCV-specific CD8+ T-cell subset featuring memory-associated states.

Journal: Frontiers in immunology

Published: May 16, 2026

Toward precision immunotherapy in recurrent/metastatic head and neck squamous cell carcinoma: lessons from the FOCUS trial.

Toward precision immunotherapy in recurrent/metastatic head and neck squamous cell carcinoma: lessons from the FOCUS trial.

Journal: Translational cancer research

Published: April 16, 2026

OncoMimic peptide-based immunotherapy EO2401 induces shared T cell clusters in patients with adrenal cancer.

OncoMimic peptide-based immunotherapy EO2401 induces shared T cell clusters in patients with adrenal cancer.

Journal: Communications medicine

Published: February 23, 2026

High-dose chemotherapy followed by autologous stem-cell transplantation versus non-myeloablative consolidation in primary CNS lymphoma (MATRix/IELSG43): a randomised phase 3 trial.

High-dose chemotherapy followed by autologous stem-cell transplantation versus non-myeloablative consolidation in primary CNS lymphoma (MATRix/IELSG43): a randomised phase 3 trial.

Journal: Lancet (London, England)

Published: February 19, 2026

MPXV H3L elicits broadly directed CD4 T cell responses in mpox patients and MVA vaccinees.

MPXV H3L elicits broadly directed CD4 T cell responses in mpox patients and MVA vaccinees.

Journal: Npj viruses

Published: February 10, 2026

FGL-1 plasma levels correlate with markers of inflammation and severe disease during SARS-CoV-2 infection.

FGL-1 plasma levels correlate with markers of inflammation and severe disease during SARS-CoV-2 infection.

Journal: Communications medicine

Published: January 09, 2026

Tertiary lymphoid structures: prognostic insights and implications for immunotherapy in HPV-negative head and neck cancer.

Tertiary lymphoid structures: prognostic insights and implications for immunotherapy in HPV-negative head and neck cancer.

Journal: Translational cancer research

Published: November 07, 2025

Mixed-methods process evaluation of ctDNA use to guide decision-making in patients with advanced solid cancers: study protocol for a substudy of the LIQPLAT trial.

Mixed-methods process evaluation of ctDNA use to guide decision-making in patients with advanced solid cancers: study protocol for a substudy of the LIQPLAT trial.

Journal: BMJ open

Published: October 28, 2025

Cell Therapies and Bispecific Engagers: Redefining Strategies against Checkpoint Resistance.

Cell Therapies and Bispecific Engagers: Redefining Strategies against Checkpoint Resistance.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 26, 2025

Efficacy and safety of eltrombopag in combination with dexamethasone as first-line treatment in adult patients with newly diagnosed immune thrombocytopenia.

Efficacy and safety of eltrombopag in combination with dexamethasone as first-line treatment in adult patients with newly diagnosed immune thrombocytopenia.

Journal: British journal of haematology

Published: August 22, 2025

Showing 1-12 of 185

Last Updated: 09/26/2026